<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Tamsulosin from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Tamsulosin news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 01:12:48 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Tamsulosin" rel="self" type="application/rss+xml" />

	
<item><title>Silodosin Approved in Europe for Benign Prostatic Hyperplasia</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4012452&amp;HITNO=0&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tamsulosin&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4012452&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523421117%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4012452&amp;HITNO=0&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tamsulosin&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4012452&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2523421117%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PSL Group:</description></item>
<item><title>Silodosin Approved in Europe for Benign Prostatic Hyperplasia</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4006496&amp;HITNO=1&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tamsulosin&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4006496&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2520739233%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4006496&amp;HITNO=1&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tamsulosin&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4006496&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2520739233%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Doctors Guide:</description></item>
<item><title>That Sinking Feeling: Intraoperative Cataract Complications</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3881305&amp;HITNO=2&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tamsulosin&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3881305&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2453830006%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3881305&amp;HITNO=2&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tamsulosin&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3881305&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2453830006%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Ophthalmology Management:</description></item>
<item><title>GlaxoSmithKline's Duodart Will Become Decision Resources' New Clinical Gold Standard by 2013 for the Treatment</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3870695&amp;HITNO=3&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tamsulosin&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3870695&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2448888024%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3870695&amp;HITNO=3&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tamsulosin&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3870695&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2448888024%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Boston Business Journal:</description></item>
<item><title>Tamsulosin Enhances Passage of Stones in the Lower Ureter</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3867542&amp;HITNO=4&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tamsulosin&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3867542&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2447205340%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3867542&amp;HITNO=4&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tamsulosin&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3867542&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2447205340%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Modern Medicine:</description></item>
<item><title>GlaxoSmithKline's Duodart Will Become Decision Resources' New Clinical Gold Standard by 2013 for the Treatment of Benign Prostatic Hyperplasia/Male Lower Urinary Tract Symptoms</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3866945&amp;HITNO=5&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tamsulosin&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3866945&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2446914082%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3866945&amp;HITNO=5&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tamsulosin&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3866945&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2446914082%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>SmartBrief:</description></item>
<item><title>GlaxoSmithKline's Duodart Will Become Decision Resources' New Clinical Gold Standard by 2013 for the Treatment</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3865022&amp;HITNO=6&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tamsulosin&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3865022&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2446190796%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3865022&amp;HITNO=6&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tamsulosin&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3865022&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2446190796%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Columbus Business First:</description></item>
<item><title>GlaxoSmithKline's Duodart Will Become Decision Resources' New Clinical Gold Standard by 2013 for the</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3864974&amp;HITNO=7&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tamsulosin&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3864974&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2446177246%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3864974&amp;HITNO=7&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tamsulosin&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3864974&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2446177246%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Interest!ALERT:</description></item>
<item><title>GlaxoSmithKline's Duodart Will Become Decision Resources' New Clinical Gold Standard by 2013 for the Treatment</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3864940&amp;HITNO=8&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tamsulosin&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3864940&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2446160096%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3864940&amp;HITNO=8&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tamsulosin&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3864940&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2446160096%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Business Journal of Milwaukee:</description></item>
<item><title>Efficacy and Safety of Tamsulosin for the Treatment of Non-neurogenic Voiding Dysfunction in Females: A 8-Week Prospective Study</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3858318&amp;HITNO=9&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tamsulosin&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3858318&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2443251192%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3858318&amp;HITNO=9&amp;MSIZE=10&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Tamsulosin&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3858318&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2443251192%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>MDLinx:</description></item>
</channel></rss>